Welcome to the ISCB Community News Blog

This blog collects news, announcements or other information which could be of interest to our ISCB members. We are a group ISCB members who volunteer to populate this blog on a regular basis. In case you want to become an "ISCB-News Reporter" yourself, let us know: contact ISCB
Don't repost copyrighted content! The guidelines are:
- Include a link to the source page
- Include a short summary about the article. You can quote up to ONE paragraph from the original story, but not more
- Don't repost an entire articles originating from another source
- Never post content without attribution — always include the source

To post a news, please use this form.

Wednesday, July 13, 2011

Registration open for Therapeutic Applications of Computational Biology and Chemistry (TACBAC) 2012

12-14 March 2012
Wellcome Trust Conference Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK

Abstract deadline: 30 January 2012 Registration deadline: 6 February 2012

This conference will bring together leading researchers investigating computational chemistry and biology techniques as applied to advancing our ability to predict, diagnose and modulate human disease. This broad and multidisciplinary meeting will explore the major challenges in drug discovery and development where innovation in computational approaches and tools can really make a significant and tangible contribution towards novel treatments. You should attend this conference if you are a researcher interested in drug discovery, or developing or using computational approaches to the development of therapeutics, or if you are a key decision maker in a pharmaceutical or biotechnology company.

Each of the sessions, which progress from identifying disease mechanisms to implementing new therapeutic and diagnostic approaches in the clinic, will bring together experts in both the biomedical and the computational aspects of the topic under discussion. Sessions chairs will encourage discussion and contribution from the attendees.

Session topics
• Clinical implications of individual genomes
• Metabolism and biomarkers
• Computational systems biology
• Discovery of chemical probes
• Modelling xenobiotic metabolism

Scientific Programme Committee:
Lee Harland, Pfizer, UK
John Overington, EMBL-European Bioinformatics Institute, Hinxton, UK
Christoph Steinbeck, EMBL-European Bioinformatics Institute, Hinxton, UK

Speakers include:
Chas Bountra, Structural Genomics Consortium, UK
Paul Flicek, EMBL-European Bioinformatics Institute, Hinxton, UK
Ronald Frank, Helmholtz Centre for Infection Research, Germany
Bobby Glen, University of Cambridge, UK
Roy Goodacre, University of Manchester, UK
Jules Griffin, University of Cambridge, UK
Lee Harland, Pfizer, UK
Aroon Hingorani, University College London, UK
John Overington, EMBL-European Bioinformatics Institute, Hinxton, UK
Julio Saez-Rodriguez, EMBL-European Bioinformatics Institute, Hinxton, UK
Christoph Steinbeck, EMBL-European Bioinformatics Institute, Hinxton, UK
Olivier Tabourieau, Center for Biological Sequence Analysis, Denmark

URL: http://registration.hinxton.wellcome.ac.uk/display_info.asp?id=263

Contact Person: Jemma Beard (j.beard@hinxton.wellcome.ac.uk)

No comments:

Post a Comment